Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-001018

Options or other derivatives

  • CHIEF BUSINESS OFFICER acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Snow David P. CHIEF BUSINESS OFFICER 2019-09-12 Grant or award · Employee Stock Option (Right to Buy) +150,000 150,000 D: show line 1 in the form
Loading xslF345X03/form4-09132019_040911.xml…